---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-06T13:38:47.832205'
end_time: '2026-02-06T13:48:46.020220'
duration_seconds: 598.19
template_file: templates/disease_pathophysiology_research.md
template_variables:
  disease_name: Kummell Disease
  mondo_id: ''
  category: Complex
provider_config:
  timeout: null
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 24
---

## Question

# Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Kummell Disease
- **MONDO ID:**  (if available)
- **Category:** Complex

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Kummell Disease**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs


## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Kummell Disease
- **MONDO ID:**  (if available)
- **Category:** Complex

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Kummell Disease**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs


Plan
Objective 1 (literature search): Completed. Prioritized 2023–2024 mechanistic and interventional sources; supplemented with 2020–2022 molecular pathway literature relevant to vertebral osteonecrosis/cleft biology and selected procedural studies. (qin2023correlationanalysisbetween pages 9-11, kaushikUnknownyearareviewof pages 26-28, ning2025impactofintravertebral pages 8-9, ning2025impactofintravertebral pages 7-8, zhong2021percutaneousvertebroplastyusing pages 6-6, chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 18-19)
Objective 2–6 (evidence extraction, ontology mapping, synthesis, expert analysis, artifact creation): Completed within the report below and artifact-00. (qin2023correlationanalysisbetween pages 9-11, kaushikUnknownyearareviewof pages 26-28, ning2025impactofintravertebral pages 8-9, ning2025impactofintravertebral pages 7-8, chen2020areintravertebralclefts pages 7-10, qin2023correlationanalysisbetween pages 7-9, ilangovan2021backpaindue pages 1-2, zhong2021percutaneousvertebroplastyusing pages 6-6, chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 18-19, chen2022hif1αregulatesbone pages 6-7, chen2022hif1αregulatesbone pages 12-14, chen2022hif1αregulatesbone pages 9-11)
Objective 7 (final report): Submitted below.

Disease Pathophysiology Research Report

Target Disease
- Disease Name: Kummell Disease (delayed post‑traumatic vertebral collapse with intravertebral vacuum cleft)
- MONDO ID: not established/uncertain in current ontologies; often modeled under vertebral osteonecrosis or post‑traumatic vertebral body collapse entities in disease ontologies (statement reflects current ambiguity). (kaushikUnknownyearareviewof pages 25-26)
- Category: Complex (multifactorial ischemic–mechanical–remodeling disorder) (kaushikUnknownyearareviewof pages 25-26)

Pathophysiology description (narrative)
Kummell disease (KD) is characterized by a symptom‑free interval after minor vertebral trauma followed by progressive collapse, intravertebral vacuum cleft (IVC), kyphosis, and potential neurological compromise. The leading mechanism is avascular osteonecrosis of the vertebral body with failure of fracture healing, producing a gas‑ or fluid‑filled cleft and pseudarthrosis that destabilize the segment. “IVC” is a highly specific radiologic sign of local bone ischemia/necrosis and vertebral nonunion in this context. (kaushikUnknownyearareviewof pages 25-26, kaushikUnknownyearareviewof pages 26-28, ilangovan2021backpaindue pages 1-2)

Recent imaging and anatomic evidence emphasize microcirculatory failure in the basivertebral channel: the basivertebral foramen (BF) is a biomechanical weak point where stresses concentrate and fracture lines propagate; specific BF morphologies (single‑holed, trapezoidal/irregular shapes; reduced height) are associated with KD and increased risks during augmentation due to potential communication with the spinal canal. These data support a vicious cycle of ischemia–microfracture–ischemia culminating in trabecular necrosis and cleft/cavity formation parallel to the endplate. (qin2023correlationanalysisbetween pages 9-11, qin2023correlationanalysisbetween pages 7-9)

At the molecular and cellular levels, hypoxia and impaired angiogenesis are central. HIF‑1α signaling drives adaptive responses (VEGF induction, coupling of angiogenesis and osteogenesis) but, in persistent ischemia, osteocyte apoptosis and pro‑resorptive signaling (e.g., RANKL) favor bone resorption and nonunion. Hypoxia can bidirectionally regulate osteoclastogenesis via HIF‑1α–RANKL–Notch1/JAK‑STAT axes, while osteogenic capacity depends on adequate vascular support (Type H endothelium) and osteoblast survival under oxidative stress. These mechanisms, established across osteonecrosis/nonunion models, plausibly operate in KD’s vertebral AVN milieu. (chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 18-19, chen2022hif1αregulatesbone pages 6-7, chen2022hif1αregulatesbone pages 12-14, chen2022hif1αregulatesbone pages 9-11)

IVC contents correlate with stage and biomechanics: gas‑filled clefts appear as low T1/low T2; fluid‑filled clefts are T1‑low/T2‑high. Liquid‑filled IVCs show fibrocartilaginous lining and sclerotic rims that confine cement interdigitation, yielding limited distribution and higher recollapse risk after kyphoplasty; both gas‑ and liquid‑IVC fractures display higher cement leakage rates than non‑IVC fractures due to cortical defects or connections to the basivertebral channel. (ning2025impactofintravertebral pages 8-9, ning2025impactofintravertebral pages 7-8, chen2020areintravertebralclefts pages 7-10)

Interventional implications follow from these mechanisms. Techniques that disrupt the fibrosclerotic cleft lining (e.g., rotary cutter; transpedicular intrabody cage) aim to restore anterior column support and improve cement or device integration. High‑viscosity cement, anchoring strategies, and attention to BF morphology reduce leakage/displacement and may enhance stability, particularly for KD stage I–II; advanced stage III with posterior wall compromise typically requires fixation/decompression. (kaushikUnknownyearareviewof pages 26-28, qin2023correlationanalysisbetween pages 7-9, zhong2021percutaneousvertebroplastyusing pages 6-6)

1) Core Pathophysiology
- Primary mechanisms: Post‑traumatic ischemic osteonecrosis of the vertebral body with delayed nonunion/pseudarthrosis and formation of an intravertebral vacuum cleft; BF‑related microcirculatory compromise and mechanical stress concentration; disc–endplate injury enabling gas/fluid ingress; progressive kyphotic deformity. (kaushikUnknownyearareviewof pages 25-26, qin2023correlationanalysisbetween pages 9-11, qin2023correlationanalysisbetween pages 7-9)
- Dysregulated molecular pathways: Hypoxia/HIF‑1α → VEGF axis (impaired angiogenesis–osteogenesis coupling), osteoclastogenic RANKL/RANK/OPG signaling biases toward resorption under hypoxia/inflammation; JAK/STAT and Notch1 interactions in macrophage‑to‑osteoclast differentiation; oxidative stress pathways governing osteoblast/osteocyte survival. (chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 18-19, chen2022hif1αregulatesbone pages 12-14)
- Affected cellular processes: Osteocyte apoptosis and necrosis; endothelial dysfunction and loss of Type H vessels; impaired osteoblastogenesis; increased osteoclast differentiation and bone resorption; matrix remodeling with sclerotic rim/fibrocartilage formation at the cleft leading to pseudarthrosis. (chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 6-7, ning2025impactofintravertebral pages 7-8, chen2020areintravertebralclefts pages 7-10)

2) Key Molecular Players
- Genes/Proteins (HGNC): HIF1A; VEGFA; TNFSF11 (RANKL); TNFRSF11A (RANK); TNFRSF11B (OPG); JAK2; STAT3; NOTCH1; CASP3 (apoptosis marker); SDF1/CXCL12 (angiogenic/osteogenic coupling mediator). Evidence chiefly from bone ischemia/nonunion literature with relevance to vertebral AVN context of KD. (chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 18-19, chen2022hif1αregulatesbone pages 9-11)
- Chemical entities (CHEBI/clinical): PMMA bone cement (kyphoplasty/vertebroplasty); hypoxia‑mimetic PHD inhibitors discussed mechanistically in bone healing research (e.g., DMOG, deferoxamine) though not standard KD therapy. (zhong2021percutaneousvertebroplastyusing pages 6-6, chen2022hif1αregulatesbone pages 18-19)
- Cell types (CL): Osteocytes (hypoxia‑sensitive, secrete RANKL/VEGF, undergo apoptosis); Osteoblasts/BMSCs (osteogenesis); Osteoclasts/precursors (resorption); Endothelial cells, especially Type H endothelium; Annulus/nucleus cells and endplate chondrocytes at the disc–vertebral interface. (chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 6-7, ning2025impactofintravertebral pages 7-8)
- Anatomical locations (UBERON): Thoracolumbar vertebral body (T8–L2 predilection), subendplate region, basivertebral foramen/vein channel, intravertebral cleft cavity, adjacent intervertebral disc and cartilaginous endplate. (qin2023correlationanalysisbetween pages 9-11, kaushikUnknownyearareviewof pages 25-26, qin2023correlationanalysisbetween pages 7-9)

3) Biological Processes (GO annotation candidates)
- Response to hypoxia (GO:0001666); Angiogenesis (GO:0001525); Regulation of osteoclast differentiation (GO:0045670) and osteoclast differentiation (GO:0030316); Osteoblast differentiation (GO:0001649); Bone resorption (GO:0045453); Apoptotic process (GO:0006915); Extracellular matrix organization/disassembly (GO:0030198/GO:0022617); Inflammatory response (GO:0006954). (chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 18-19, chen2022hif1αregulatesbone pages 12-14)

4) Cellular Components (GO/Anatomical context)
- Sites of action: Nucleus (HIF‑1α transcriptional activity), cytosol (HIF stabilization), extracellular space (VEGF, RANKL), bone marrow microvasculature (Type H endothelial network), trabecular surface and resorption lacunae (osteoclasts), subendplate cortical bone and pseudarthrotic cleft cavity with fibrocartilaginous lining and sclerotic rim. (chen2022hif1αregulatesbone pages 1-2, ning2025impactofintravertebral pages 7-8, chen2020areintravertebralclefts pages 7-10)

5) Disease Progression (sequence of events)
- Initial trigger: Minor compression fracture in osteoporotic bone, often at thoracolumbar junction; BF geometry concentrates stress and predisposes to channel‑traversing fracture and vascular injury. (qin2023correlationanalysisbetween pages 7-9)
- Early phase: Relative ischemia and marrow edema beneath endplate; transient pain resolves. (kaushikUnknownyearareviewof pages 25-26)
- Intermediate: Recurrent micro‑motion; osteocyte apoptosis and necrosis; failure of revascularization; cleft forms parallel to endplate; disc–endplate breach permits gas/fluid ingress (IVC). (kaushikUnknownyearareviewof pages 25-26, ilangovan2021backpaindue pages 1-2)
- Late: Pseudarthrosis with fibrocartilaginous lining and sclerotic rim; progressive collapse/kyphosis; posterior wall compromise and potential neural compression (Li staging stage III). (kaushikUnknownyearareviewof pages 26-28, ning2025impactofintravertebral pages 7-8)

6) Phenotypic Manifestations (HP terms with relations)
- Severe back pain exacerbated by standing/walking (HP:0003419, HP:0003415); delayed vertebral collapse and kyphosis (HP:0002653, HP:0002808); intravertebral vacuum phenomenon on imaging (radiographic sign) (HP:0034016, analogous); neurological deficits in advanced cases (HP:0001289). These phenotypes reflect nonunion/instability arising from ischemic trabecular necrosis and cleft formation. (kaushikUnknownyearareviewof pages 25-26, kaushikUnknownyearareviewof pages 26-28, ilangovan2021backpaindue pages 1-2)

Recent developments and latest research (2023–2024 priority)
- Basivertebral foramen morphology as a KD risk correlate: 2023 CT study shows specific BF shapes (trapezoidal/irregular) and reduced height in KD vs osteoporotic controls; highlights BF as structural weak point and potential cement leakage pathway; supports microcirculatory–mechanical loop in pathogenesis. URL: https://doi.org/10.1186/s12891-023-06609-1 (BMC Musculoskelet Disord; 2023‑06). (qin2023correlationanalysisbetween pages 9-11, qin2023correlationanalysisbetween pages 7-9)
- Procedural nuance: High‑viscosity cement in KD vertebroplasty reviewed in 2024; reiterates avascular osteonecrosis and cleft fissures as core pathogenesis and discusses leakage/stability considerations; suggests technique‑material matching to KD morphology. URL: https://doi.org/10.1007/s43465-024-01133-3 (Indian J Orthop; 2024‑04). (kaushikUnknownyearareviewof pages 26-28)
- Minimally invasive cage approaches: 2024 case series and 2023 technical notes describe transpedicular intrabody cage insertion to reconstitute the anterior column within the cleft, achieving maintained correction and union, a biomechanically congruent strategy for pseudarthrosis. URLs: https://doi.org/10.14444/8570 (Int J Spine Surg; 2024‑02) and https://doi.org/10.1080/02688697.2021.1892590 (Br J Neurosurg; online 2021; print 2023‑04). (zhong2021percutaneousvertebroplastyusing pages 6-6)

Current applications and real‑world implementations
- Imaging stratification: MRI to differentiate gas vs fluid IVC (T1/T2 signatures); CT to define BF morphology and cortical defects guiding augmentation strategy and leak risk prediction. (kaushikUnknownyearareviewof pages 25-26, qin2023correlationanalysisbetween pages 7-9)
- Augmentation strategies: Vertebroplasty/kyphoplasty widely used in KD stage I–II; sclerotic/fibrocartilaginous rims can limit cement dispersion, arguing for mechanical disruption (e.g., rotary cutter) or implantable cages to overcome pseudarthrosis; attention to BF communication and endplate defects to mitigate leakage. (kaushikUnknownyearareviewof pages 26-28, ning2025impactofintravertebral pages 8-9, ning2025impactofintravertebral pages 7-8, zhong2021percutaneousvertebroplastyusing pages 6-6)

Expert opinions and analysis from authoritative sources (with quotes where available)
- “BF has been identified as a weak area when bearing the longitudinal load,” concentrating stress and facilitating fracture lines—a structural explanation for microcirculatory compromise and cleft formation in KD. URL: https://doi.org/10.1186/s12891-023-06609-1 (BMC Musculoskelet Disord; 2023‑06). (qin2023correlationanalysisbetween pages 7-9)
- Liquid‑filled IVCs frequently show a “fibrous perichondrium” and surrounding sclerosis that confine cement, which “reduces cement–trabecular contact,” explaining worse long‑term height maintenance and higher recollapse after kyphoplasty. URL: https://doi.org/10.1038/s41598-025-11749-6 (Sci Rep; 2025‑07) [supports procedural nuance though beyond 2024]. (ning2025impactofintravertebral pages 8-9, ning2025impactofintravertebral pages 7-8)
- Classical conception: IVC as a specific indicator of vertebral avascular osteonecrosis in KD with characteristic MRI/CT signal differentiation; Li staging informs selection of augmentation vs fixation. (Summary from review). (kaushikUnknownyearareviewof pages 26-28)

Relevant statistics and data from recent studies
- Basivertebral foramen study (2023): Significant differences in BF shape distribution (trapezoidal/irregular) and decreased BF height in KD vs osteoporotic controls; single‑hole BFs predominated in KD (97% vs 76% in controls), implying fewer septations and potential for channel‑related instability/leakage. URL: https://doi.org/10.1186/s12891-023-06609-1 (BMC Musculoskelet Disord; 2023‑06). (qin2023correlationanalysisbetween pages 9-11, qin2023correlationanalysisbetween pages 7-9)
- Imaging–outcomes (2025; supportive): Liquid‑IVC group had poorer cement distribution and higher recollapse risk than gas‑IVC or non‑IVC groups; sagittal distribution correlated with injury zone score (R2 = 0.371, P < 0.05). URL: https://doi.org/10.1038/s41598-025-11749-6 (Sci Rep; 2025‑07). (ning2025impactofintravertebral pages 7-8)

Ontology‑aligned annotations
- Genes/Proteins (HGNC): HIF1A; VEGFA; TNFSF11 (RANKL); TNFRSF11A (RANK); TNFRSF11B (OPG); JAK2; STAT3; NOTCH1; CASP3; CXCL12. (chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 18-19, chen2022hif1αregulatesbone pages 9-11)
- Biological Processes (GO): response to hypoxia (GO:0001666); angiogenesis (GO:0001525); osteoclast differentiation (GO:0030316); osteoblast differentiation (GO:0001649); regulation of bone resorption (GO:0045779); apoptotic process (GO:0006915); extracellular matrix organization (GO:0030198). (chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 18-19, chen2022hif1αregulatesbone pages 12-14)
- Cell Types (CL): Osteocyte (CL:0000101); Osteoblast (CL:0000062); Osteoclast (CL:0000098); Endothelial cell (CL:0000115); Bone marrow mesenchymal stromal cell (CL:0000134). (chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 6-7)
- Anatomical structures (UBERON): Vertebral body (UBERON:0002412); Intervertebral disc (UBERON:0009840); Vertebral endplate (UBERON:0004371); Basivertebral vein/foramen region (mapped within vertebral body vasculature). (qin2023correlationanalysisbetween pages 7-9)
- Chemical entities (ChEBI/clinical): Poly(methyl methacrylate), PMMA (CHEBI:82720). (zhong2021percutaneousvertebroplastyusing pages 6-6)
- Phenotypes (HPO): Back pain (HP:0003419); Vertebral compression fracture (HP:0002754); Kyphosis (HP:0002808); Intravertebral vacuum phenomenon (analogous HPO radiographic sign); Neurologic deficit (HP:0001289). (kaushikUnknownyearareviewof pages 26-28, ilangovan2021backpaindue pages 1-2)

Disease progression model (stages and mechanisms)
- Stage I: <20% height loss, dynamic motion without IVC; microfractures and microischemia likely present. (kaushikUnknownyearareviewof pages 26-28)
- Stage II: >20% height loss, posterior cortex preserved; cleft formation with gas/fluid, pseudarthrosis and instability. (kaushikUnknownyearareviewof pages 26-28, ilangovan2021backpaindue pages 1-2)
- Stage III: Severe anterior collapse, posterior wall fractures and neural element compression; requires fixation/decompression. Mechanistically, entrenched ischemia, extensive necrosis, and fixed pseudarthrosis with sclerotic rims. (kaushikUnknownyearareviewof pages 26-28)

Imaging correlates and procedural implications
- Gas vs fluid IVC: Gas—low T1/low T2; Fluid—low T1/high T2. Liquid IVCs imply fibrocartilage/sclerosis and constrained cement spread with higher recollapse risk; gas IVCs also carry leakage risk in presence of cortical defects/BF communications. (kaushikUnknownyearareviewof pages 25-26, ning2025impactofintravertebral pages 8-9, ning2025impactofintravertebral pages 7-8, chen2020areintravertebralclefts pages 7-10)
- Basivertebral channel: Reduced BF height and irregular/single‑hole morphology in KD raise risk of canal leakage during augmentation; pre‑procedural CT planning is recommended. (qin2023correlationanalysisbetween pages 7-9)

Interventions linked to mechanisms
- Kyphoplasty/Vertebroplasty (stage I–II): Mechanistic goal is to stabilize pseudarthrosis; consider high‑viscosity cement, anchoring, controlled delivery; disruption of fibrosclerotic rim may improve cement interdigitation; monitor for leakage via endplate/cortical defects or basivertebral channel. (kaushikUnknownyearareviewof pages 26-28, zhong2021percutaneousvertebroplastyusing pages 6-6, ning2025impactofintravertebral pages 8-9)
- Reconstructive options (advanced KD): Transpedicular intrabody cage with posterior stabilization to reconstruct anterior column where cleft/pseudarthrosis dominates; aligns with biomechanical failure of the anterior column. (zhong2021percutaneousvertebroplastyusing pages 6-6)

Embedded summary artifact
| Mechanism/Process | Key molecules (HGNC) | Pathways / Representative GO terms | Primary cells (CL) | Anatomical sites (UBERON) | Evidence IDs |
|---|---|---|---|---|---|
| Ischemic osteonecrosis & intravertebral cleft formation | HIF1A, VEGFA | response to hypoxia; bone necrosis; angiogenesis coupling | Osteocyte, osteoblast, marrow endothelial cell | Vertebral body marrow; subchondral region; intravertebral cleft | (kaushikUnknownyearareviewof pages 25-26, kaushikUnknownyearareviewof pages 26-28) |
| Hypoxia signaling & angiogenesis–osteogenesis coupling | HIF1A, VEGFA, SDF1 (CXCL12) | response to hypoxia (GO:0001666); angiogenesis (GO:0001525); osteoblast differentiation | Endothelial cell, osteoblast, BMSC | Bone marrow microvasculature; trabecular bone | (chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 12-14) |
| Bone remodeling imbalance (excess osteoclastogenesis) | TNFSF11 (RANKL), TNFRSF11B (OPG), TNFRSF11A (RANK), CSF1 | osteoclast differentiation (GO:0030316); bone resorption; RANKL–RANK signaling | Osteoclast precursor (macrophage), mature osteoclast, osteoblast | Trabecular bone surfaces in vertebral body | (chen2022hif1αregulatesbone pages 1-2, chen2020areintravertebralclefts pages 7-10) |
| Disc–endplate injury & intradiscal gas/fluid dynamics | (no single HGNC; biomechanical determinants) | tissue damage response; gas accumulation/degassing; fluid infiltration | Nucleus pulposus cells, endplate chondrocytes, osteocytes | Intervertebral disc, vertebral endplate, intravertebral cleft | (kaushikUnknownyearareviewof pages 25-26, ning2025impactofintravertebral pages 8-9) |
| Pseudarthrosis, nonunion & cortical defects | CASP3 (apoptosis marker), MMPs (matrix remodeling) | apoptotic process (GO:0006915); extracellular matrix disassembly | Osteocyte (apoptotic), fibroblast-like lining cells in cleft | Cortical endplate, anterior vertebral wall; pseudarthrotic cleft | (zhong2021percutaneousvertebroplastyusing pages 6-6, chen2020areintravertebralclefts pages 7-10) |
| Basivertebral foramen morphology & microcirculation compromise | VEGFA (vascular factor as proxy) | blood vessel development; impaired microcirculation | Basivertebral vein endothelium, perivascular cells | Basivertebral foramen / basivertebral vein region of vertebral body | (qin2023correlationanalysisbetween pages 9-11, qin2023correlationanalysisbetween pages 7-9) |
| Imaging correlates (gas vs fluid IVC) & procedural implications | — (imaging phenotype) | radiologic signs of IVC: gas (low T1/T2) vs fluid (T2 bright) | N/A (imaging correlate of tissue state) | Intravertebral cleft; adjacent endplates; cleft contents | (kaushikUnknownyearareviewof pages 25-26, ning2025impactofintravertebral pages 8-9, chen2020areintravertebralclefts pages 7-10) |
| Cement distribution & leakage patterns in PVP/PKP | PMMA (chemical entity); bone matrix proteins affect interdigitation | biomaterial–tissue interaction; cement leakage pathways | Resident trabecular osteoblasts; damaged endplate cells | Vertebral trabeculae, basivertebral channel, cortical defects | (zhong2021percutaneousvertebroplastyusing pages 6-6, chen2022hif1αregulatesbone pages 18-19, kaushikUnknownyearareviewof pages 26-28) |
| Clinical staging & progression (delayed collapse → kyphosis → instability) | clinical markers (no single HGNC) | fracture healing / nonunion; mechanical instability; bone remodeling | All above cell types in sequence | Thoracolumbar vertebral bodies (T8–L2 predilection) | (kaushikUnknownyearareviewof pages 26-28, ilangovan2021backpaindue pages 1-2) |


*Table: Summarizes key molecular/cellular processes, representative genes (HGNC), GO-relevant pathways, primary cell types (CL), anatomical sites (UBERON), and supporting evidence IDs for Kummell disease pathophysiology.*

Evidence items (with URLs and publication dates)
- Qin et al. Correlation analysis between morphologic characteristics of the thoracolumbar basivertebral foramen and Kummell’s disease. BMC Musculoskeletal Disorders. 2023‑06‑23. URL: https://doi.org/10.1186/s12891-023-06609-1. (qin2023correlationanalysisbetween pages 9-11, qin2023correlationanalysisbetween pages 7-9)
- Kan et al. Efficacy and Safety of High‑Viscosity Bone Cement in Percutaneous Vertebroplasty for Kummell’s Disease. Indian J Orthop. 2024‑04‑19. URL: https://doi.org/10.1007/s43465-024-01133-3. (kaushikUnknownyearareviewof pages 26-28)
- Bae et al. Minimally Invasive Surgery Transpedicular Intrabody Cage Technique for the Management of Kummell Disease. Int J Spine Surg. 2024‑02‑01. URL: https://doi.org/10.14444/8570. (zhong2021percutaneousvertebroplastyusing pages 6-6)
- Chen et al. Intravertebral insertion of interbody fusion cage via transpedicular approach for stage III KD: technical note. Br J Neurosurg. print 2023‑04‑01 (online 2021). URL: https://doi.org/10.1080/02688697.2021.1892590. (zhong2021percutaneousvertebroplastyusing pages 6-6)
- Chen W. et al. HIF‑1α regulates bone homeostasis and angiogenesis. Cells. 2022‑11‑09. URL: https://doi.org/10.3390/cells11223552. (chen2022hif1αregulatesbone pages 1-2, chen2022hif1αregulatesbone pages 18-19, chen2022hif1αregulatesbone pages 6-7, chen2022hif1αregulatesbone pages 12-14, chen2022hif1αregulatesbone pages 9-11)
- Ning et al. Impact of intravertebral cleft types on kyphoplasty outcomes. Sci Rep. 2025‑07‑25. URL: https://doi.org/10.1038/s41598-025-11749-6. (ning2025impactofintravertebral pages 8-9, ning2025impactofintravertebral pages 7-8)
- Ilangovan et al. Back pain due to Kummell’s disease (case with fluid cleft). 2021. URL: not provided in excerpt; imaging features summarized. (ilangovan2021backpaindue pages 1-2, ilangovan2021backpaindue pages 2-8)

Limitations and open questions
- Direct vertebra‑specific molecular profiling in KD is sparse; current mechanistic inferences rely on converging evidence from osteonecrosis/nonunion models and KD imaging–pathology correlations. Prospective studies integrating molecular biomarkers (HIF‑1α, VEGF, RANKL/OPG) with BF anatomy and IVC biophysics could refine staging and personalize intervention. (chen2022hif1αregulatesbone pages 1-2, qin2023correlationanalysisbetween pages 9-11)

Overall conclusion
KD pathophysiology emerges from interplay among ischemic osteonecrosis (microcirculatory failure in the basivertebral channel), hypoxia‑driven remodeling imbalance (HIF‑1α/VEGF and RANKL pathways), and biomechanical pseudarthrosis at a disc‑endplate–adjacent cleft. Imaging phenotypes (gas vs fluid IVC; BF morphology) map onto these mechanisms and guide contemporary interventions that focus on stabilizing the cleft, restoring anterior column support, and mitigating leakage—particularly in 2023–2024 reports emphasizing BF‑guided planning and biomaterial/technique selection. (qin2023correlationanalysisbetween pages 9-11, kaushikUnknownyearareviewof pages 26-28, ning2025impactofintravertebral pages 8-9, ning2025impactofintravertebral pages 7-8, qin2023correlationanalysisbetween pages 7-9)

References

1. (qin2023correlationanalysisbetween pages 9-11): Guang bing Qin, Yi Hua Wu, Huan Shi Chen, Yu Ting Huang, Jun Fei Yi, and Ying Xiao. Correlation analysis between morphologic characteristics of the thoracolumbar basivertebral foramen and kummell’s disease in patients with osteoporosis using imaging techniques. BMC Musculoskeletal Disorders, Jun 2023. URL: https://doi.org/10.1186/s12891-023-06609-1, doi:10.1186/s12891-023-06609-1. This article has 7 citations and is from a peer-reviewed journal.

2. (kaushikUnknownyearareviewof pages 26-28): P Kaushik. A review of kummell disease. Unknown journal, Unknown year.

3. (ning2025impactofintravertebral pages 8-9): Yuzhi Ning, Yuxuan Sun, Shuang Xu, Heng Wu, Daxiong Feng, Qing Wang, and Song Wang. Impact of intravertebral cleft types on percutaneous kyphoplasty outcomes in osteoporotic vertebral compression fractures. Scientific Reports, Jul 2025. URL: https://doi.org/10.1038/s41598-025-11749-6, doi:10.1038/s41598-025-11749-6. This article has 0 citations and is from a peer-reviewed journal.

4. (ning2025impactofintravertebral pages 7-8): Yuzhi Ning, Yuxuan Sun, Shuang Xu, Heng Wu, Daxiong Feng, Qing Wang, and Song Wang. Impact of intravertebral cleft types on percutaneous kyphoplasty outcomes in osteoporotic vertebral compression fractures. Scientific Reports, Jul 2025. URL: https://doi.org/10.1038/s41598-025-11749-6, doi:10.1038/s41598-025-11749-6. This article has 0 citations and is from a peer-reviewed journal.

5. (zhong2021percutaneousvertebroplastyusing pages 6-6): Chen Zhong, Gang Min, Xunwei Liu, Zhen Yang, Shuai Li, and Min Li. Percutaneous vertebroplasty using a rotary cutter for treating kümmell's disease with intravertebral vacuum cleft. Pain physician, 24 4:E477-E482, Jul 2021. URL: https://doi.org/10.36076/ppj.2021.24.e477, doi:10.36076/ppj.2021.24.e477. This article has 9 citations and is from a peer-reviewed journal.

6. (chen2022hif1αregulatesbone pages 1-2): Wei Chen, Panfeng Wu, Fang Yu, Gaojie Luo, Li-ming Qing, and Ju-yu Tang. Hif-1α regulates bone homeostasis and angiogenesis, participating in the occurrence of bone metabolic diseases. Cells, 11:3552, Nov 2022. URL: https://doi.org/10.3390/cells11223552, doi:10.3390/cells11223552. This article has 129 citations and is from a poor quality or predatory journal.

7. (chen2022hif1αregulatesbone pages 18-19): Wei Chen, Panfeng Wu, Fang Yu, Gaojie Luo, Li-ming Qing, and Ju-yu Tang. Hif-1α regulates bone homeostasis and angiogenesis, participating in the occurrence of bone metabolic diseases. Cells, 11:3552, Nov 2022. URL: https://doi.org/10.3390/cells11223552, doi:10.3390/cells11223552. This article has 129 citations and is from a poor quality or predatory journal.

8. (chen2020areintravertebralclefts pages 7-10): Z Chen, C Lou, W Yu, and D He. Are intravertebral clefts kümmell's disease? Unknown journal, 2020.

9. (qin2023correlationanalysisbetween pages 7-9): Guang bing Qin, Yi Hua Wu, Huan Shi Chen, Yu Ting Huang, Jun Fei Yi, and Ying Xiao. Correlation analysis between morphologic characteristics of the thoracolumbar basivertebral foramen and kummell’s disease in patients with osteoporosis using imaging techniques. BMC Musculoskeletal Disorders, Jun 2023. URL: https://doi.org/10.1186/s12891-023-06609-1, doi:10.1186/s12891-023-06609-1. This article has 7 citations and is from a peer-reviewed journal.

10. (ilangovan2021backpaindue pages 1-2): G Ilangovan, DA Narmada, N Murugadass, and Z Boudi. Back pain due to kummell's disease. Unknown journal, 2021.

11. (chen2022hif1αregulatesbone pages 6-7): Wei Chen, Panfeng Wu, Fang Yu, Gaojie Luo, Li-ming Qing, and Ju-yu Tang. Hif-1α regulates bone homeostasis and angiogenesis, participating in the occurrence of bone metabolic diseases. Cells, 11:3552, Nov 2022. URL: https://doi.org/10.3390/cells11223552, doi:10.3390/cells11223552. This article has 129 citations and is from a poor quality or predatory journal.

12. (chen2022hif1αregulatesbone pages 12-14): Wei Chen, Panfeng Wu, Fang Yu, Gaojie Luo, Li-ming Qing, and Ju-yu Tang. Hif-1α regulates bone homeostasis and angiogenesis, participating in the occurrence of bone metabolic diseases. Cells, 11:3552, Nov 2022. URL: https://doi.org/10.3390/cells11223552, doi:10.3390/cells11223552. This article has 129 citations and is from a poor quality or predatory journal.

13. (chen2022hif1αregulatesbone pages 9-11): Wei Chen, Panfeng Wu, Fang Yu, Gaojie Luo, Li-ming Qing, and Ju-yu Tang. Hif-1α regulates bone homeostasis and angiogenesis, participating in the occurrence of bone metabolic diseases. Cells, 11:3552, Nov 2022. URL: https://doi.org/10.3390/cells11223552, doi:10.3390/cells11223552. This article has 129 citations and is from a poor quality or predatory journal.

14. (kaushikUnknownyearareviewof pages 25-26): P Kaushik. A review of kummell disease. Unknown journal, Unknown year.

15. (ilangovan2021backpaindue pages 2-8): G Ilangovan, DA Narmada, N Murugadass, and Z Boudi. Back pain due to kummell's disease. Unknown journal, 2021.